193K New Covid Cases, 710 Deaths In U.S.

vaccinecampaign june30 lt

As many as 193,201 people were reported Covid positive in the United States on Wednesday. With this, the total number of people that have been infected with the coronavirus in the country rose to 87,411,319, as per the latest data by the Center for Systems Science and Engineering at Johns Hopkins University.

710 Covid deaths reported on the same day took the total U.S. Covid casualties to 1,017,470.

1,772 additional deaths were reported globally on Wednesday, taking the total number of people who lost their lives due to the pandemic so far to 6,334,660.

North Carolina reported the most number of cases - 23,136, while Georgia reported the highest number of deaths - 123.

Deaths have increased by 18 percent and cases by seven percent in the last two weeks, New York Times' latest tally shows.

More than 32,000 people are currently in American hospitals with Covid infection, an increase of 9 percent over the last two weeks. More than 3,500 of these patients are admitted in intensive care units, marking a 8 percent increase in a fortnight.

84,810,554 people have so far recovered from the disease, the Worldometer tally shows.

The U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, has announced an agreement to purchase more than 100 million doses of Pfizer's new Covid-19 vaccine for a Fall Vaccine Campaign.

The $3.2 billion contract includes a combination of adult and pediatric doses with a portion of the adult doses provided as single-dose vials, a first for COVID-19 vaccines.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT